Search
Searching Content indexed under Product Liability & Safety by DLA Piper Australia ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
Unravelling the Helix - marketing and promoting pharmaceutical products
A hypothetical scenario involving the marketing of pharmaceutical products.
Australia
10 Sep 2013
2
PLC Multi-Jurisdictional Guide 2012: Life Sciences - Part 3
Part 3 of the Guide includes a Product Liability section and future possible reforms of the therapeutic goods industry.
Australia
21 May 2012
3
Doing Business in Australia - Business Practices
Federal and state laws and regulations in Australia combine to influence how business practices are conducted.
Australia
30 Apr 2012
4
Warranties Against Defects - A New Regulation Will Apply From 1 January 2011
Manufacturers, retailers and service providers will need to act soon to review and revise documents containing warranties against defects so that they will be ready to comply with a new regulation taking effect on 1 January 2012
Australia
21 Apr 2011
5
Product Liability Update : Seeds, Shrimps And Cigarettes
One recent product liability case looks at the distinction between an ‘occurrence’ and ‘damage’ in a liability policy: Selected Seeds Pty Ltd v QBEMM Pty Ltd [2009] QSC 70.
Australia
10 Jul 2009
6
Product Recall Exclusions
Recently, there has been publicity about suppliers recalling their products manufactured in China. Should insurers be concerned?
Australia
25 Jan 2008
7
Asbestos Litigation – Two Product Liability Cases
The recent decisions of these cases show that breach of duty and causation are still difficult to prove in dust disease cases.
Australia
21 Jan 2008
8
Tort Law Reform - The Final Chapter
The tort law reform process in Australia is now complete with the commencement of the Trade Practices Amendment (Personal Injuries and Death) Act 2006 (Cth) ("the Amendment Act"). Proceedings for personal injuries and death are no longer permitted under the consumer protection provisions of Part V, Division 1 of the Trade Practices Act 1974 (Cth) ("the TPA"). Part V, Division 1 of the TPA includes section 52 which contains the well-known prohibition on misleading or deceptive conduct.
Australia
12 May 2006
9
Quick Dose
Child resistant packaging requirements for therapeutic goods are currently regulated in Australia by the Therapeutic Goods Administration under Therapeutic Goods Order No. 65 (TGA65) - Child Resistant Packaging for Therapeutic goods. In New Zealand the area is overseen by Medsafe under the Regulations to the Medicines Act (1981). The recent draft order addressing child resistant packaging of therapeutic products is the result of an attempt to harmonise Australian and New Zealand standards in thi
Australia
11 May 2006
10
Government Signals Tighter Regulation of Complementary Medicines
Following the Pan Pharmaceuticals product recall in April 2003, the Commonwealth Government established an Expert Committee to report on the adequacy of the current regulation of complementary medicines.
Australia
29 Nov 2005
11
Clinical Trials Under the Microscope
The Therapeutic Goods Administration ("TGA") and the National Health and Medical Research Council ("NH&MRC") handed down their report on the Review of Access to Unapproved Therapeutic Goods in Australia in late February this year.
Australia
29 Nov 2005
12
Liability For Manufacturers Who Supply Unmerchantable Goods - A Novel Statutory Cause Of Action Available To Australian Plaintiffs
Until recent times, product liability claimants in Australia typically relied upon negligence to establish a right to damages, pleading in the alternative misleading or deceptive conduct under section 52 of the Trade Practices Act 1974 (Cth) ("the TPA"), and a breach of one or more of the statutory causes of action against manufacturers and importers of defective products contained within Part V Division 2A and Part VA of the TPA.
Australia
28 Apr 2005
Links to Result pages
 
1